#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


1-1	0-10	Functional	_
1-2	11-18	network	_
1-3	19-26	changes	_
1-4	27-30	and	_
1-5	31-40	cognitive	_
1-6	41-48	control	_
1-7	49-51	in	_
1-8	52-65	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
1-9	66-75	Cognitive	_
1-10	76-83	control	_
1-11	84-86	is	_
1-12	87-88	a	_
1-13	89-98	cognitive	_
1-14	99-102	and	_
1-15	103-109	neural	_
1-16	110-119	mechanism	_
1-17	120-124	that	_
1-18	125-136	contributes	_
1-19	137-139	to	_
1-20	140-148	managing	_
1-21	149-152	the	_
1-22	153-160	complex	_
1-23	161-168	demands	_
1-24	169-171	of	_
1-25	172-182	day-to-day	_
1-26	183-187	life	_
1-27	188-189	.	_

2-1	190-197	Studies	_
2-2	198-202	have	_
2-3	203-212	suggested	_
2-4	213-217	that	_
2-5	218-228	functional	_
2-6	229-240	impairments	_
2-7	241-243	in	_
2-8	244-253	cognitive	_
2-9	254-261	control	_
2-10	262-272	associated	_
2-11	273-278	brain	_
2-12	279-288	circuitry	_
2-13	289-299	contribute	_
2-14	300-302	to	_
2-15	303-304	a	_
2-16	305-310	broad	_
2-17	311-316	range	_
2-18	317-319	of	_
2-19	320-326	higher	_
2-20	327-336	cognitive	_
2-21	337-345	deficits	_
2-22	346-348	in	_
2-23	349-362	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
2-24	363-364	.	_

3-1	365-367	To	_
3-2	368-375	examine	_
3-3	376-380	this	_
3-4	381-386	issue	_
3-5	387-388	,	_
3-6	389-391	we	_
3-7	392-400	assessed	_
3-8	401-411	functional	_
3-9	412-424	connectivity	_
3-10	425-433	networks	_
3-11	434-436	in	_
3-12	437-444	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-13	445-451	adults	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
3-14	452-455	and	_
3-15	456-467	individuals	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-16	468-472	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-17	473-486	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
3-18	487-497	performing	_
3-19	498-503	tasks	_
3-20	504-508	from	_
3-21	509-512	two	_
3-22	513-521	distinct	_
3-23	522-531	cognitive	_
3-24	532-539	domains	_
3-25	540-544	that	_
3-26	545-551	varied	_
3-27	552-554	in	_
3-28	555-562	demands	_
3-29	563-566	for	_
3-30	567-576	cognitive	_
3-31	577-584	control	_
3-32	585-586	,	_
3-33	587-590	the	_
3-34	591-595	RiSE	_
3-35	596-604	episodic	_
3-36	605-611	memory	_
3-37	612-616	task	_
3-38	617-620	and	_
3-39	621-624	DPX	_
3-40	625-629	goal	_
3-41	630-641	maintenance	_
3-42	642-646	task	_
3-43	647-648	.	_

4-1	649-651	We	_
4-2	652-665	characterized	_
4-3	666-673	general	_
4-4	674-677	and	_
4-5	678-687	cognitive	_
4-6	688-704	control-specific	_
4-7	705-712	effects	_
4-8	713-715	of	_
4-9	716-729	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
4-10	730-732	on	_
4-11	733-743	functional	_
4-12	744-756	connectivity	_
4-13	757-763	within	_
4-14	764-766	an	_
4-15	767-775	expanded	_
4-16	776-783	frontal	_
4-17	784-792	parietal	_
4-18	793-800	network	_
4-19	801-802	(	_
4-20	803-806	FPN	_
4-21	807-808	)	_
4-22	809-812	and	_
4-23	813-823	quantified	_
4-24	824-831	network	_
4-25	832-840	topology	_
4-26	841-851	properties	_
4-27	852-857	using	_
4-28	858-863	graph	_
4-29	864-872	analysis	_
4-30	873-874	.	_

5-1	875-880	Using	_
5-2	881-884	the	_
5-3	885-892	network	_
5-4	893-898	based	_
5-5	899-908	statistic	_
5-6	909-910	(	_
5-7	911-914	NBS	_
5-8	915-916	)	_
5-9	917-918	,	_
5-10	919-921	we	_
5-11	922-930	observed	_
5-12	931-938	greater	_
5-13	939-946	network	_
5-14	947-957	functional	_
5-15	958-970	connectivity	_
5-16	971-973	in	_
5-17	974-983	cognitive	_
5-18	984-991	control	_
5-19	992-1001	demanding	_
5-20	1002-1012	conditions	_
5-21	1013-1019	during	_
5-22	1020-1024	both	_
5-23	1025-1030	tasks	_
5-24	1031-1033	in	_
5-25	1034-1038	both	_
5-26	1039-1045	groups	_
5-27	1046-1048	in	_
5-28	1049-1052	the	_
5-29	1053-1056	FPN	_
5-30	1057-1058	,	_
5-31	1059-1062	and	_
5-32	1063-1075	demonstrated	_
5-33	1076-1085	cognitive	_
5-34	1086-1093	control	_
5-35	1094-1097	FPN	_
5-36	1098-1109	specificity	_
5-37	1110-1117	against	_
5-38	1118-1119	a	_
5-39	1120-1124	task	_
5-40	1125-1136	independent	_
5-41	1137-1145	auditory	_
5-42	1146-1153	network	_
5-43	1154-1155	.	_

6-1	1156-1159	NBS	_
6-2	1160-1168	analyses	_
6-3	1169-1173	also	_
6-4	1174-1182	revealed	_
6-5	1183-1193	widespread	_
6-6	1194-1206	connectivity	_
6-7	1207-1215	deficits	_
6-8	1216-1218	in	_
6-9	1219-1232	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-10	1233-1241	patients	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
6-11	1242-1248	across	_
6-12	1249-1252	all	_
6-13	1253-1258	tasks	_
6-14	1259-1260	.	_

7-1	1261-1272	Furthermore	_
7-2	1273-1274	,	_
7-3	1275-1287	quantitative	_
7-4	1288-1295	changes	_
7-5	1296-1298	in	_
7-6	1299-1306	network	_
7-7	1307-1315	topology	_
7-8	1316-1326	associated	_
7-9	1327-1331	with	_
7-10	1332-1342	diagnostic	_
7-11	1343-1349	status	_
7-12	1350-1353	and	_
7-13	1354-1358	task	_
7-14	1359-1365	demand	_
7-15	1366-1370	were	_
7-16	1371-1379	observed	_
7-17	1380-1381	.	_

8-1	1382-1385	The	_
8-2	1386-1393	present	_
8-3	1394-1402	findings	_
8-4	1403-1404	,	_
8-5	1405-1407	in	_
8-6	1408-1410	an	_
8-7	1411-1419	analysis	_
8-8	1420-1424	that	_
8-9	1425-1428	was	_
8-10	1429-1436	limited	_
8-11	1437-1439	to	_
8-12	1440-1447	correct	_
8-13	1448-1454	trials	_
8-14	1455-1459	only	_
8-15	1460-1461	,	_
8-16	1462-1470	ensuring	_
8-17	1471-1475	that	_
8-18	1476-1484	subjects	_
8-19	1485-1488	are	_
8-20	1489-1491	on	_
8-21	1492-1496	task	_
8-22	1497-1498	,	_
8-23	1499-1506	provide	_
8-24	1507-1515	critical	_
8-25	1516-1524	insights	_
8-26	1525-1529	into	_
8-27	1530-1537	network	_
8-28	1538-1549	connections	_
8-29	1550-1557	crucial	_
8-30	1558-1561	for	_
8-31	1562-1571	cognitive	_
8-32	1572-1579	control	_
8-33	1580-1583	and	_
8-34	1584-1587	the	_
8-35	1588-1594	manner	_
8-36	1595-1597	in	_
8-37	1598-1603	which	_
8-38	1604-1609	brain	_
8-39	1610-1618	networks	_
8-40	1619-1629	reorganize	_
8-41	1630-1632	to	_
8-42	1633-1640	support	_
8-43	1641-1645	such	_
8-44	1646-1653	control	_
8-45	1654-1655	.	_

9-1	1656-1667	Impairments	_
9-2	1668-1670	in	_
9-3	1671-1675	this	_
9-4	1676-1685	mechanism	_
9-5	1686-1689	are	_
9-6	1690-1697	present	_
9-7	1698-1700	in	_
9-8	1701-1714	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
9-9	1715-1718	and	_
9-10	1719-1724	these	_
9-11	1725-1732	results	_
9-12	1733-1742	highlight	_
9-13	1743-1746	how	_
9-14	1747-1756	cognitive	_
9-15	1757-1764	control	_
9-16	1765-1773	deficits	_
9-17	1774-1784	contribute	_
9-18	1785-1787	to	_
9-19	1788-1791	the	_
9-20	1792-1807	pathophysiology	_
9-21	1808-1810	of	_
9-22	1811-1815	this	_
9-23	1816-1823	illness	_
9-24	1824-1825	.	_

10-1	1826-1836	Highlights	_
10-2	1837-1847	Functional	_
10-3	1848-1860	connectivity	_
10-4	1861-1868	changes	_
10-5	1869-1871	in	_
10-6	1872-1875	the	_
10-7	1876-1879	FPN	_
10-8	1880-1887	support	_
10-9	1888-1897	effective	_
10-10	1898-1905	periods	_
10-11	1906-1908	of	_
10-12	1909-1918	cognitive	_
10-13	1919-1926	control	_
10-14	1927-1928	.	_

11-1	1929-1938	Decreased	_
11-2	1939-1949	functional	_
11-3	1950-1962	connectivity	_
11-4	1963-1965	in	_
11-5	1966-1979	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
11-6	1980-1983	was	_
11-7	1984-1992	observed	_
11-8	1993-1995	in	_
11-9	1996-1999	all	_
11-10	2000-2009	cognitive	_
11-11	2010-2017	control	_
11-12	2018-2023	tasks	_
11-13	2024-2025	.	_

12-1	2026-2029	The	_
12-2	2030-2033	NBS	_
12-3	2034-2044	identified	_
12-4	2045-2050	nodes	_
12-5	2051-2053	in	_
12-6	2054-2057	the	_
12-7	2058-2061	PFC	_
12-8	2062-2065	and	_
12-9	2066-2069	MTL	_
12-10	2070-2079	exhibited	_
12-11	2080-2085	group	_
12-12	2086-2088	by	_
12-13	2089-2096	control	_
12-14	2097-2108	interaction	_
12-15	2109-2116	effects	_
12-16	2117-2118	.	_

13-1	2119-2126	Changes	_
13-2	2127-2129	in	_
13-3	2130-2133	FPN	_
13-4	2134-2142	topology	_
13-5	2143-2153	associated	_
13-6	2154-2158	with	_
13-7	2159-2169	diagnostic	_
13-8	2170-2176	status	_
13-9	2177-2180	and	_
13-10	2181-2185	task	_
13-11	2186-2192	demand	_
13-12	2193-2197	were	_
13-13	2198-2206	observed	_
13-14	2207-2208	.	_

14-1	2209-2218	Materials	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
14-2	2219-2222	and	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
14-3	2223-2230	methods	http://maven.renci.org/NeuroBridge/neurobridge#StudyMethod
14-4	2231-2239	Subjects	_
14-5	2240-2245	Study	_
14-6	2246-2258	participants	_
14-7	2259-2263	were	_
14-8	2264-2273	recruited	_
14-9	2274-2276	as	_
14-10	2277-2281	part	_
14-11	2282-2284	of	_
14-12	2285-2288	the	_
14-13	2289-2296	CNTRACS	_
14-14	2297-2307	Consortium	_
14-15	2308-2309	(	_
14-16	2310-2314	http	_
14-17	2315-2316	:	_
14-18	2317-2338	//cntracs.ucdavis.edu	_
14-19	2339-2340	)	_
14-20	2341-2342	,	_
14-21	2343-2348	which	_
14-22	2349-2357	included	_
14-23	2358-2359	5	_
14-24	2360-2369	different	_
14-25	2370-2378	research	_
14-26	2379-2384	sites	_
14-27	2385-2386	:	_
14-28	2387-2397	University	_
14-29	2398-2400	of	_
14-30	2401-2417	California—Davis	_
14-31	2418-2419	,	_
14-32	2420-2428	Maryland	_
14-33	2429-2440	Psychiatric	_
14-34	2441-2449	Research	_
14-35	2450-2456	Center	_
14-36	2457-2459	at	_
14-37	2460-2463	the	_
14-38	2464-2474	University	_
14-39	2475-2477	of	_
14-40	2478-2486	Maryland	_
14-41	2487-2488	,	_
14-42	2489-2492	and	_
14-43	2493-2500	Rutgers	_
14-44	2501-2511	University	_
14-45	2512-2519	–Robert	_
14-46	2520-2524	Wood	_
14-47	2525-2532	Johnson	_
14-48	2533-2540	Medical	_
14-49	2541-2547	School	_
14-50	2548-2549	,	_
14-51	2550-2560	University	_
14-52	2561-2563	of	_
14-53	2564-2578	Minnesota—Twin	_
14-54	2579-2585	Cities	_
14-55	2586-2587	,	_
14-56	2588-2591	and	_
14-57	2592-2602	Washington	_
14-58	2603-2613	University	_
14-59	2614-2615	.	_

15-1	2616-2627	Recruitment	_
15-2	2628-2631	and	_
15-3	2632-2640	informed	_
15-4	2641-2648	consent	_
15-5	2649-2659	procedures	_
15-6	2660-2663	for	_
15-7	2664-2668	each	_
15-8	2669-2673	site	_
15-9	2674-2678	were	_
15-10	2679-2687	approved	_
15-11	2688-2690	by	_
15-12	2691-2696	their	_
15-13	2697-2710	Institutional	_
15-14	2711-2717	Review	_
15-15	2718-2724	Boards	_
15-16	2725-2726	.	_

16-1	2727-2735	Complete	_
16-2	2736-2743	details	_
16-3	2744-2753	regarding	_
16-4	2754-2761	CNTRACS	_
16-5	2762-2773	recruitment	_
16-6	2774-2777	and	_
16-7	2778-2788	enrollment	_
16-8	2789-2792	can	_
16-9	2793-2795	be	_
16-10	2796-2801	found	_
16-11	2802-2804	in	_
16-12	2805-2806	.	_

17-1	2807-2811	Data	_
17-2	2812-2816	were	_
17-3	2817-2825	obtained	_
17-4	2826-2828	on	_
17-5	2829-2831	60	_
17-6	2832-2834	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
17-7	2835-2838	and	_
17-8	2839-2841	60	_
17-9	2842-2844	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
17-10	2845-2857	participants	_
17-11	2858-2859	.	_

18-1	2860-2872	Participants	_
18-2	2873-2877	were	_
18-3	2878-2886	excluded	_
18-4	2887-2889	if	_
18-5	2890-2894	they	_
18-6	2895-2904	exhibited	_
18-7	2905-2911	excess	_
18-8	2912-2920	movement	_
18-9	2921-2922	(	_
18-10	2923-2927	i.e.	_
18-11	2928-2929	,	_
18-12	2930-2931	>	_
18-13	2932-2936	0.37	_
18-14	2937-2939	mm	_
18-15	2940-2948	relative	_
18-16	2949-2963	frame-to-frame	_
18-17	2964-2972	movement	_
18-18	2973-2974	)	_
18-19	2975-2976	,	_
18-20	2977-2989	below-chance	_
18-21	2990-3001	performance	_
18-22	3002-3003	,	_
18-23	3004-3006	or	_
18-24	3007-3012	image	_
18-25	3013-3024	acquisition	_
18-26	3025-3031	errors	_
18-27	3032-3033	.	_

19-1	3034-3038	This	_
19-2	3039-3043	left	_
19-3	3044-3049	final	_
19-4	3050-3057	samples	_
19-5	3058-3060	of	_
19-6	3061-3063	56	_
19-7	3064-3066	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-8	3067-3068	(	_
19-9	3069-3073	34.0	_
19-10	3074-3075	±	_
19-11	3076-3080	11.4	_
19-12	3081-3084	yrs	_
19-13	3085-3086	)	_
19-14	3087-3090	and	_
19-15	3091-3093	52	_
19-16	3094-3096	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
19-17	3097-3098	(	_
19-18	3099-3103	33.8	_
19-19	3104-3105	±	_
19-20	3106-3110	11.8	_
19-21	3111-3114	yrs	_
19-22	3115-3116	)	_
19-23	3117-3120	for	_
19-24	3121-3124	the	_
19-25	3125-3129	RiSE	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
19-26	3130-3134	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
19-27	3135-3136	,	_
19-28	3137-3140	and	_
19-29	3141-3143	52	_
19-30	3144-3146	HC	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
19-31	3147-3148	(	_
19-32	3149-3153	34.1	_
19-33	3154-3155	±	_
19-34	3156-3160	11.4	_
19-35	3161-3164	yrs	_
19-36	3165-3166	)	_
19-37	3167-3170	and	_
19-38	3171-3173	45	_
19-39	3174-3176	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
19-40	3177-3178	(	_
19-41	3179-3183	34.2	_
19-42	3184-3185	±	_
19-43	3186-3190	11.7	_
19-44	3191-3194	yrs	_
19-45	3195-3196	)	_
19-46	3197-3199	of	_
19-47	3200-3203	the	_
19-48	3204-3208	same	_
19-49	3209-3217	subjects	_
19-50	3218-3221	for	_
19-51	3222-3225	DPX	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
19-52	3226-3230	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
19-53	3231-3232	(	_
19-54	3233-3238	Table	_
19-55	3239-3240	1	_
19-56	3241-3242	)	_
19-57	3243-3244	.	_

20-1	3245-3251	Groups	_
20-2	3252-3256	were	_
20-3	3257-3264	matched	_
20-4	3265-3268	for	_
20-5	3269-3272	age	_
20-6	3273-3274	,	_
20-7	3275-3278	sex	_
20-8	3279-3280	,	_
20-9	3281-3291	handedness	_
20-10	3292-3293	,	_
20-11	3294-3302	parental	_
20-12	3303-3312	education	_
20-13	3313-3318	level	_
20-14	3319-3320	,	_
20-15	3321-3324	and	_
20-16	3325-3334	estimated	_
20-17	3335-3344	premorbid	_
20-18	3345-3357	intelligence	_
20-19	3358-3359	(	_
20-20	3360-3368	Weschler	_
20-21	3369-3373	Test	_
20-22	3374-3376	of	_
20-23	3377-3382	Adult	_
20-24	3383-3390	Reading	_
20-25	3391-3392	)	_
20-26	3393-3394	.	_

21-1	3395-3406	Individuals	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
21-2	3407-3411	with	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
21-3	3412-3425	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
21-4	3426-3434	obtained	_
21-5	3435-3440	fewer	_
21-6	3441-3446	years	_
21-7	3447-3449	of	_
21-8	3450-3456	school	_
21-9	3457-3461	than	_
21-10	3462-3469	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-11	3470-3478	controls	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
21-12	3479-3480	,	_
21-13	3481-3487	likely	_
21-14	3488-3498	reflecting	_
21-15	3499-3509	disruption	_
21-16	3510-3516	caused	_
21-17	3517-3519	by	_
21-18	3520-3527	illness	_
21-19	3528-3533	onset	_
21-20	3534-3535	.	_

22-1	3536-3544	Patients	_
22-2	3545-3549	were	_
22-3	3550-3560	clinically	_
22-4	3561-3567	stable	_
22-5	3568-3569	,	_
22-6	3570-3573	and	_
22-7	3574-3578	were	_
22-8	3579-3591	experiencing	_
22-9	3592-3596	mild	_
22-10	3597-3605	symptoms	_
22-11	3606-3607	.	_

23-1	3608-3611	All	_
23-2	3612-3615	but	_
23-3	3616-3617	4	_
23-4	3618-3626	patients	_
23-5	3627-3631	were	_
23-6	3632-3641	receiving	_
23-7	3642-3652	medication	_
23-8	3653-3656	for	_
23-9	3657-3659	at	_
23-10	3660-3665	least	_
23-11	3666-3669	one	_
23-12	3670-3675	month	_
23-13	3676-3677	(	_
23-14	3678-3679	2	_
23-15	3680-3696	first-generation	_
23-16	3697-3711	antipsychotics	_
23-17	3712-3713	,	_
23-18	3714-3716	41	_
23-19	3717-3734	second-generation	_
23-20	3735-3749	antipsychotics	_
23-21	3750-3751	,	_
23-22	3752-3753	4	_
23-23	3754-3760	first-	_
23-24	3761-3764	and	_
23-25	3765-3782	second-generation	_
23-26	3783-3797	antipsychotics	_
23-27	3798-3799	)	_
23-28	3800-3801	.	_

24-1	3802-3808	Groups	_
24-2	3809-3813	were	_
24-3	3814-3817	not	_
24-4	3818-3831	significantly	_
24-5	3832-3841	different	_
24-6	3842-3846	with	_
24-7	3847-3853	regard	_
24-8	3854-3856	to	_
24-9	3857-3865	absolute	_
24-10	3866-3868	or	_
24-11	3869-3877	relative	_
24-12	3878-3882	head	_
24-13	3883-3891	movement	_
24-14	3892-3893	(	_
24-15	3894-3898	RISE	_
24-16	3899-3900	:	_
24-17	3901-3902	p	_
24-18	3903-3904	=	_
24-19	3905-3910	0.114	_
24-20	3911-3912	;	_
24-21	3913-3916	DPX	_
24-22	3917-3918	:	_
24-23	3919-3920	p	_
24-24	3921-3922	=	_
24-25	3923-3928	0.278	_
24-26	3929-3930	)	_
24-27	3931-3932	.	_

25-1	3933-3936	See	_
25-2	3937-3949	Supplemental	_
25-3	3950-3958	material	_
25-4	3959-3962	for	_
25-5	3963-3971	movement	_
25-6	3972-3981	scrubbing	_
25-7	3982-3992	procedures	_
25-8	3993-3994	.	_

26-1	3995-3999	Data	_
26-2	4000-4011	acquisition	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
26-3	4012-4016	RiSE	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
26-4	4017-4021	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
26-5	4022-4024	To	_
26-6	4025-4032	briefly	_
26-7	4033-4041	describe	_
26-8	4042-4045	the	_
26-9	4046-4050	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImagingProtocol
26-10	4051-4059	paradigm	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImagingProtocol
26-11	4060-4061	,	_
26-12	4062-4074	participants	_
26-13	4075-4084	completed	_
26-14	4085-4087	an	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
26-15	4088-4096	encoding	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
26-16	4097-4100	run	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
26-17	4101-4109	followed	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
26-18	4110-4112	by	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
26-19	4113-4114	a	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
26-20	4115-4124	retrieval	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
26-21	4125-4128	run	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
26-22	4129-4130	.	_

27-1	4131-4137	During	_
27-2	4138-4146	encoding	_
27-3	4147-4148	(	_
27-4	4149-4162	Supplementary	_
27-5	4163-4166	Fig	_
27-6	4167-4168	.	_

28-1	4169-4172	S1A	_
28-2	4173-4174	)	_
28-3	4175-4176	,	_
28-4	4177-4189	participants	_
28-5	4190-4200	alternated	_
28-6	4201-4208	between	_
28-7	4209-4222	item-specific	_
28-8	4223-4229	blocks	_
28-9	4230-4231	(	_
28-10	4232-4233	“	_
28-11	4234-4236	Is	_
28-12	4237-4243	either	_
28-13	4244-4250	object	_
28-14	4251-4257	living	_
28-15	4258-4259	?	_
28-16	4260-4261	”	_
28-17	4262-4263	)	_
28-18	4264-4267	and	_
28-19	4268-4278	relational	_
28-20	4279-4285	blocks	_
28-21	4286-4287	(	_
28-22	4288-4289	“	_
28-23	4290-4293	Can	_
28-24	4294-4297	one	_
28-25	4298-4304	object	_
28-26	4305-4308	fit	_
28-27	4309-4315	inside	_
28-28	4316-4319	the	_
28-29	4320-4325	other	_
28-30	4326-4327	?	_
28-31	4328-4329	”	_
28-32	4330-4331	)	_
28-33	4332-4334	in	_
28-34	4335-4336	a	_
28-35	4337-4338	“	_
28-36	4339-4347	jittered	_
28-37	4348-4349	”	_
28-38	4350-4363	event-related	_
28-39	4364-4370	design	_
28-40	4371-4372	.	_

29-1	4373-4379	During	_
29-2	4380-4384	item	_
29-3	4385-4396	recognition	_
29-4	4397-4398	(	_
29-5	4399-4412	Supplementary	_
29-6	4413-4416	Fig	_
29-7	4417-4418	.	_

30-1	4419-4422	S1B	_
30-2	4423-4424	)	_
30-3	4425-4426	,	_
30-4	4427-4439	participants	_
30-5	4440-4449	indicated	_
30-6	4450-4457	whether	_
30-7	4458-4465	objects	_
30-8	4466-4470	were	_
30-9	4471-4481	previously	_
30-10	4482-4489	studied	_
30-11	4490-4491	(	_
30-12	4492-4493	“	_
30-13	4494-4497	old	_
30-14	4498-4499	”	_
30-15	4500-4501	)	_
30-16	4502-4504	or	_
30-17	4505-4518	never-studied	_
30-18	4519-4520	(	_
30-19	4521-4522	“	_
30-20	4523-4526	new	_
30-21	4527-4528	”	_
30-22	4529-4530	)	_
30-23	4531-4532	.	_

31-1	4533-4545	Participants	_
31-2	4546-4555	completed	_
31-3	4556-4557	4	_
31-4	4558-4566	encoding	_
31-5	4567-4570	and	_
31-6	4571-4572	4	_
31-7	4573-4584	recognition	_
31-8	4585-4589	runs	_
31-9	4590-4594	that	_
31-10	4595-4599	were	_
31-11	4600-4604	used	_
31-12	4605-4608	for	_
31-13	4609-4617	analysis	_
31-14	4618-4619	.	_

32-1	4620-4623	DPX	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-2	4624-4628	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-3	4629-4632	The	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-4	4633-4636	DPX	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-5	4637-4641	task	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-6	4642-4651	consisted	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-7	4652-4654	of	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-8	4655-4656	a	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-9	4657-4665	sequence	http://maven.renci.org/NeuroBridge/neurobridge#TaskParadigmImaging
32-10	4666-4668	of	_
32-11	4669-4678	cue-probe	_
32-12	4679-4686	stimuli	http://maven.renci.org/NeuroBridge/neurobridge#StimulantDependence
32-13	4687-4692	where	_
32-14	4693-4705	participants	_
32-15	4706-4710	made	_
32-16	4711-4714	one	_
32-17	4715-4723	response	_
32-18	4724-4728	when	_
32-19	4729-4730	a	_
32-20	4731-4737	target	_
32-21	4738-4747	cue-probe	_
32-22	4748-4752	pair	_
32-23	4753-4756	was	_
32-24	4757-4766	presented	_
32-25	4767-4770	and	_
32-26	4771-4778	another	_
32-27	4779-4787	response	_
32-28	4788-4791	for	_
32-29	4792-4795	all	_
32-30	4796-4801	other	_
32-31	4802-4809	stimuli	_
32-32	4810-4811	(	_
32-33	4812-4825	Supplementary	_
32-34	4826-4829	Fig	_
32-35	4830-4831	.	_

33-1	4832-4834	S2	_
33-2	4835-4836	)	_
33-3	4837-4838	.	_

34-1	4839-4843	Cues	_
34-2	4844-4853	indicated	_
34-3	4854-4857	the	_
34-4	4858-4862	need	_
34-5	4863-4866	for	_
34-6	4867-4871	high	_
34-7	4872-4873	(	_
34-8	4874-4875	B	_
34-9	4876-4880	Cues	_
34-10	4881-4882	)	_
34-11	4883-4885	or	_
34-12	4886-4889	low	_
34-13	4890-4891	(	_
34-14	4892-4893	A	_
34-15	4894-4898	Cues	_
34-16	4899-4900	)	_
34-17	4901-4907	levels	_
34-18	4908-4910	of	_
34-19	4911-4920	cognitive	_
34-20	4921-4928	control	_
34-21	4929-4930	.	_

35-1	4931-4943	Participants	_
35-2	4944-4953	completed	_
35-3	4954-4955	4	_
35-4	4956-4960	runs	_
35-5	4961-4963	of	_
35-6	4964-4967	the	_
35-7	4968-4971	DPX	_
35-8	4972-4976	task	http://maven.renci.org/NeuroBridge/neurobridge#BackTaskTest
35-9	4977-4981	that	_
35-10	4982-4986	were	_
35-11	4987-4991	used	_
35-12	4992-4995	for	_
35-13	4996-5004	analysis	_
35-14	5005-5006	.	_

36-1	5007-5010	See	_
36-2	5011-5014	the	_
36-3	5015-5028	Supplementary	_
36-4	5029-5040	information	_
36-5	5041-5043	or	_
36-6	5044-5047	for	_
36-7	5048-5052	more	_
36-8	5053-5059	detail	_
36-9	5060-5061	.	_

37-1	5062-5075	Preprocessing	_
37-2	5076-5082	Images	_
37-3	5083-5087	were	_
37-4	5088-5096	acquired	_
37-5	5097-5099	in	_
37-6	5100-5101	a	_
37-7	5102-5108	single	_
37-8	5109-5111	3T	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
37-9	5112-5115	MRI	http://maven.renci.org/NeuroBridge/neurobridge#MagneticResonanceImaging
37-10	5116-5123	session	_
37-11	5124-5129	using	_
37-12	5130-5131	a	_
37-13	5132-5142	consistent	_
37-14	5143-5151	protocol	_
37-15	5152-5158	across	_
37-16	5159-5164	sites	_
37-17	5165-5166	.	_

38-1	5167-5181	Administration	_
38-2	5182-5184	of	_
38-3	5185-5188	the	_
38-4	5189-5193	RiSE	http://maven.renci.org/NeuroBridge/neurobridge#LowRisk
38-5	5194-5197	and	_
38-6	5198-5201	DPX	http://maven.renci.org/NeuroBridge/neurobridge#Thing
38-7	5202-5207	tasks	_
38-8	5208-5211	was	_
38-9	5212-5227	counterbalanced	_
38-10	5228-5234	across	_
38-11	5235-5243	subjects	_
38-12	5244-5245	.	_

39-1	5246-5256	Functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
39-2	5257-5263	images	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
39-3	5264-5268	were	_
39-4	5269-5277	acquired	_
39-5	5278-5283	using	_
39-6	5284-5297	gradient-echo	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
39-7	5298-5302	BOLD	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
39-8	5303-5314	echo-planar	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
39-9	5315-5322	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
39-10	5323-5324	(	_
39-11	5325-5327	TR	_
39-12	5328-5329	=	_
39-13	5330-5334	2000	_
39-14	5335-5337	ms	_
39-15	5338-5339	,	_
39-16	5340-5342	TE	_
39-17	5343-5344	=	_
39-18	5345-5347	30	_
39-19	5348-5350	ms	_
39-20	5351-5352	,	_
39-21	5353-5356	77°	_
39-22	5357-5361	flip	_
39-23	5362-5367	angle	_
39-24	5368-5369	,	_
39-25	5370-5373	FOV	_
39-26	5374-5375	=	_
39-27	5376-5379	220	_
39-28	5380-5383	mm2	_
39-29	5384-5385	,	_
39-30	5386-5390	3.43	_
39-31	5391-5392	×	_
39-32	5393-5397	3.43	_
39-33	5398-5399	×	_
39-34	5400-5401	4	_
39-35	5402-5404	mm	_
39-36	5405-5411	voxels	_
39-37	5412-5413	,	_
39-38	5414-5416	32	_
39-39	5417-5422	axial	_
39-40	5423-5429	slices	_
39-41	5430-5438	parallel	_
39-42	5439-5443	with	_
39-43	5444-5447	the	_
39-44	5448-5466	anterior/posterior	_
39-45	5467-5477	commissure	_
39-46	5478-5479	)	_
39-47	5480-5481	.	_

40-1	5482-5485	For	_
40-2	5486-5490	more	_
40-3	5491-5502	information	_
40-4	5503-5506	see	_
40-5	5507-5508	.	_

41-1	5509-5523	Pre-processing	_
41-2	5524-5527	was	_
41-3	5528-5535	carried	_
41-4	5536-5539	out	_
41-5	5540-5545	using	_
41-6	5546-5549	the	_
41-7	5550-5554	FMRI	_
41-8	5555-5561	Expert	_
41-9	5562-5570	Analysis	_
41-10	5571-5575	Tool	_
41-11	5576-5577	(	_
41-12	5578-5582	FEAT	_
41-13	5583-5584	)	_
41-14	5585-5587	in	_
41-15	5588-5591	the	_
41-16	5592-5597	FMRIB	_
41-17	5598-5606	Software	_
41-18	5607-5614	Library	_
41-19	5615-5616	(	_
41-20	5617-5620	FSL	_
41-21	5621-5628	version	_
41-22	5629-5632	4.1	_
41-23	5633-5634	;	_
41-24	5635-5657	www.fmrib.ox.ac.uk/fsl	_
41-25	5658-5659	)	_
41-26	5660-5665	using	_
41-27	5666-5674	standard	_
41-28	5675-5685	procedures	_
41-29	5686-5687	,	_
41-30	5688-5697	including	_
41-31	5698-5706	fieldmap	_
41-32	5707-5717	correction	_
41-33	5718-5719	,	_
41-34	5720-5727	spatial	_
41-35	5728-5741	normalization	_
41-36	5742-5745	and	_
41-37	5746-5755	nonlinear	_
41-38	5756-5768	registration	_
41-39	5769-5771	to	_
41-40	5772-5778	MNI152	_
41-41	5779-5780	(	_
41-42	5781-5784	Fig	_
41-43	5785-5786	.	_

42-1	5787-5788	1	_
42-2	5789-5790	:	_
42-3	5791-5795	Step	_
42-4	5796-5797	1	_
42-5	5798-5799	)	_
42-6	5800-5801	.	_

43-1	5802-5807	Field	_
43-2	5808-5812	maps	_
43-3	5813-5815	to	_
43-4	5816-5823	correct	_
43-5	5824-5828	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
43-6	5829-5833	data	_
43-7	5834-5837	for	_
43-8	5838-5847	geometric	_
43-9	5848-5858	distortion	_
43-10	5859-5865	caused	_
43-11	5866-5868	by	_
43-12	5869-5877	magnetic	_
43-13	5878-5883	field	_
43-14	5884-5899	inhomogeneities	_
43-15	5900-5903	and	_
43-16	5904-5905	a	_
43-17	5906-5917	T1-weighted	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
43-18	5918-5928	anatomical	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
43-19	5929-5934	image	http://maven.renci.org/NeuroBridge/neurobridge#T1WeightedImaging
43-20	5935-5936	(	_
43-21	5937-5941	1-mm	_
43-22	5942-5951	isotropic	_
43-23	5952-5958	voxels	_
43-24	5959-5960	)	_
43-25	5961-5965	were	_
43-26	5966-5970	also	_
43-27	5971-5979	acquired	_
43-28	5980-5981	.	_

44-1	5982-5986	Data	_
44-2	5987-5997	processing	_
44-3	5998-5999	(	_
44-4	6000-6011	Beta-series	_
44-5	6012-6022	regression	_
44-6	6023-6024	)	_
44-7	6025-6037	Subject-wise	_
44-8	6038-6049	beta-series	_
44-9	6050-6060	regression	_
44-10	6061-6069	analysis	_
44-11	6070-6073	was	_
44-12	6074-6083	performed	_
44-13	6084-6086	on	_
44-14	6087-6091	RiSE	_
44-15	6092-6095	and	_
44-16	6096-6099	DPX	_
44-17	6100-6104	fMRI	_
44-18	6105-6109	data	_
44-19	6110-6112	in	_
44-20	6113-6118	order	_
44-21	6119-6121	to	_
44-22	6122-6129	capture	_
44-23	6130-6135	trial	_
44-24	6136-6144	specific	_
44-25	6145-6149	BOLD	_
44-26	6150-6157	effects	_
44-27	6158-6161	for	_
44-28	6162-6166	each	_
44-29	6167-6176	condition	_
44-30	6177-6178	.	_

45-1	6179-6181	To	_
45-2	6182-6189	measure	_
45-3	6190-6203	event-related	_
45-4	6204-6214	functional	_
45-5	6215-6227	connectivity	_
45-6	6228-6229	,	_
45-7	6230-6240	individual	_
45-8	6241-6247	trials	_
45-9	6248-6252	were	_
45-10	6253-6260	modeled	_
45-11	6261-6265	with	_
45-12	6266-6267	a	_
45-13	6268-6274	unique	_
45-14	6275-6280	delta	_
45-15	6281-6289	function	_
45-16	6290-6291	,	_
45-17	6292-6301	convolved	_
45-18	6302-6306	with	_
45-19	6307-6308	a	_
45-20	6309-6318	canonical	_
45-21	6319-6330	hemodynamic	_
45-22	6331-6339	response	_
45-23	6340-6348	function	_
45-24	6349-6350	,	_
45-25	6351-6356	using	_
45-26	6357-6361	SPM8	_
45-27	6362-6363	.	_

46-1	6364-6367	The	_
46-2	6368-6375	ability	_
46-3	6376-6378	to	_
46-4	6379-6384	model	_
46-5	6385-6395	individual	_
46-6	6396-6402	trials	_
46-7	6403-6409	within	_
46-8	6410-6412	an	_
46-9	6413-6426	event-related	_
46-10	6427-6433	design	_
46-11	6434-6444	highlights	_
46-12	6445-6446	a	_
46-13	6447-6453	unique	_
46-14	6454-6463	advantage	_
46-15	6464-6475	beta-series	_
46-16	6476-6486	regression	_
46-17	6487-6495	provides	_
46-18	6496-6499	the	_
46-19	6500-6507	current	_
46-20	6508-6518	functional	_
46-21	6519-6531	connectivity	_
46-22	6532-6540	analysis	_
46-23	6541-6545	over	_
46-24	6546-6556	previously	_
46-25	6557-6564	applied	_
46-26	6565-6579	pseudo-resting	_
46-27	6580-6585	state	_
46-28	6586-6587	,	_
46-29	6588-6590	or	_
46-30	6591-6595	task	_
46-31	6596-6606	regression	_
46-32	6607-6608	,	_
46-33	6609-6619	approaches	_
46-34	6620-6621	.	_

47-1	6622-6624	In	_
47-2	6625-6626	a	_
47-3	6627-6641	pseudo-resting	_
47-4	6642-6647	state	_
47-5	6648-6656	analysis	_
47-6	6657-6658	,	_
47-7	6659-6669	functional	_
47-8	6670-6682	connectivity	_
47-9	6683-6685	is	_
47-10	6686-6695	typically	_
47-11	6696-6704	measured	_
47-12	6705-6715	throughout	_
47-13	6716-6718	an	_
47-14	6719-6725	entire	_
47-15	6726-6729	run	_
47-16	6730-6735	where	_
47-17	6736-6739	all	_
47-18	6740-6746	trials	_
47-19	6747-6750	are	_
47-20	6751-6758	treated	_
47-21	6759-6770	identically	_
47-22	6771-6772	.	_

48-1	6773-6776	The	_
48-2	6777-6784	current	_
48-3	6785-6790	study	_
48-4	6791-6799	benefits	_
48-5	6800-6804	from	_
48-6	6805-6808	the	_
48-7	6809-6816	ability	_
48-8	6817-6819	of	_
48-9	6820-6823	the	_
48-10	6824-6835	beta-series	_
48-11	6836-6846	regression	_
48-12	6847-6849	to	_
48-13	6850-6855	model	_
48-14	6856-6862	events	_
48-15	6863-6871	uniquely	_
48-16	6872-6873	,	_
48-17	6874-6878	thus	_
48-18	6879-6887	allowing	_
48-19	6888-6890	us	_
48-20	6891-6893	to	_
48-21	6894-6901	examine	_
48-22	6902-6909	changes	_
48-23	6910-6912	in	_
48-24	6913-6923	functional	_
48-25	6924-6936	connectivity	_
48-26	6937-6944	between	_
48-27	6945-6950	trial	_
48-28	6951-6956	types	_
48-29	6957-6958	(	_
48-30	6959-6962	i.e	_
48-31	6963-6964	.	_

49-1	6965-6975	functional	_
49-2	6976-6988	connectivity	_
49-3	6989-6999	associated	_
49-4	7000-7004	with	_
49-5	7005-7014	cognitive	_
49-6	7015-7022	control	_
49-7	7023-7029	demand	_
49-8	7030-7031	)	_
49-9	7032-7033	.	_

50-1	7034-7042	Separate	_
50-2	7043-7053	regressors	_
50-3	7054-7062	modeling	_
50-4	7063-7067	each	_
50-5	7068-7073	event	_
50-6	7074-7078	were	_
50-7	7079-7086	defined	_
50-8	7087-7089	in	_
50-9	7090-7091	a	_
50-10	7092-7099	general	_
50-11	7100-7106	linear	_
50-12	7107-7112	model	_
50-13	7113-7115	to	_
50-14	7116-7121	yield	_
50-15	7122-7128	unique	_
50-16	7129-7143	condition-wise	_
50-17	7144-7148	beta	_
50-18	7149-7155	values	_
50-19	7156-7159	for	_
50-20	7160-7165	every	_
50-21	7166-7171	voxel	_
50-22	7172-7173	(	_
50-23	7174-7177	Fig	_
50-24	7178-7179	.	_

51-1	7180-7181	1	_
51-2	7182-7183	:	_
51-3	7184-7188	Step	_
51-4	7189-7190	2	_
51-5	7191-7192	)	_
51-6	7193-7194	.	_

52-1	7195-7199	Each	_
52-2	7200-7204	beta	_
52-3	7205-7210	value	_
52-4	7211-7220	reflected	_
52-5	7221-7224	the	_
52-6	7225-7234	magnitude	_
52-7	7235-7237	of	_
52-8	7238-7241	the	_
52-9	7242-7253	hemodynamic	_
52-10	7254-7262	response	_
52-11	7263-7269	evoked	_
52-12	7270-7272	by	_
52-13	7273-7277	each	_
52-14	7278-7283	event	_
52-15	7284-7285	.	_

53-1	7286-7290	Beta	_
53-2	7291-7297	images	_
53-3	7298-7302	were	_
53-4	7303-7309	sorted	_
53-5	7310-7312	by	_
53-6	7313-7322	condition	_
53-7	7323-7326	and	_
53-8	7327-7339	concatenated	_
53-9	7340-7346	across	_
53-10	7347-7351	runs	_
53-11	7352-7360	yielding	_
53-12	7361-7362	a	_
53-13	7363-7365	4D	_
53-14	7366-7373	dataset	_
53-15	7374-7375	(	_
53-16	7376-7381	space	_
53-17	7382-7383	x	_
53-18	7384-7385	n	_
53-19	7386-7392	trials	_
53-20	7393-7394	)	_
53-21	7395-7396	,	_
53-22	7397-7399	or	_
53-23	7400-7411	beta-series	_
53-24	7412-7413	,	_
53-25	7414-7417	for	_
53-26	7418-7422	each	_
53-27	7423-7432	condition	_
53-28	7433-7434	(	_
53-29	7435-7438	Fig	_
53-30	7439-7440	.	_

54-1	7441-7442	1	_
54-2	7443-7444	:	_
54-3	7445-7449	Step	_
54-4	7450-7451	3	_
54-5	7452-7453	)	_
54-6	7454-7455	.	_

55-1	7456-7461	While	_
55-2	7462-7465	all	_
55-3	7466-7472	events	_
55-4	7473-7477	were	_
55-5	7478-7485	modeled	_
55-6	7486-7487	,	_
55-7	7488-7492	only	_
55-8	7493-7496	cue	_
55-9	7497-7503	events	_
55-10	7504-7507	for	_
55-11	7508-7511	DPX	_
55-12	7512-7519	correct	_
55-13	7520-7526	trials	_
55-14	7527-7530	and	_
55-15	7531-7538	correct	_
55-16	7539-7543	RiSE	_
55-17	7544-7550	trials	_
55-18	7551-7555	were	_
55-19	7556-7564	included	_
55-20	7565-7567	in	_
55-21	7568-7571	the	_
55-22	7572-7580	analysis	_
55-23	7581-7582	,	_
55-24	7583-7590	because	_
55-25	7591-7596	these	_
55-26	7597-7608	represented	_
55-27	7609-7614	trial	_
55-28	7615-7622	periods	_
55-29	7623-7625	in	_
55-30	7626-7631	which	_
55-31	7632-7641	cognitive	_
55-32	7642-7649	control	_
55-33	7650-7657	demands	_
55-34	7658-7662	were	_
55-35	7663-7672	maximized	_
55-36	7673-7674	.	_

56-1	7675-7679	Next	_
56-2	7680-7681	,	_
56-3	7682-7686	each	_
56-4	7687-7698	participant	_
56-5	7699-7701	's	_
56-6	7702-7707	brain	_
56-7	7708-7711	was	_
56-8	7712-7723	parcellated	_
56-9	7724-7728	into	_
56-10	7729-7737	discrete	_
56-11	7738-7745	regions	_
56-12	7746-7748	of	_
56-13	7749-7757	interest	_
56-14	7758-7770	representing	_
56-15	7771-7776	nodes	_
56-16	7777-7782	using	_
56-17	7783-7787	from	_
56-18	7788-7791	the	_
56-19	7792-7797	Power	_
56-20	7798-7803	atlas	_
56-21	7804-7805	.	_

57-1	7806-7816	Twenty-one	_
57-2	7817-7822	Power	_
57-3	7823-7828	nodes	_
57-4	7829-7833	were	_
57-5	7834-7844	eliminated	_
57-6	7845-7848	due	_
57-7	7849-7851	to	_
57-8	7852-7855	low	_
57-9	7856-7862	signal	_
57-10	7863-7864	,	_
57-11	7865-7868	and	_
57-12	7869-7872	two	_
57-13	7873-7882	bilateral	_
57-14	7883-7886	MTL	_
57-15	7887-7892	nodes	_
57-16	7893-7897	were	_
57-17	7898-7903	added	_
57-18	7904-7905	(	_
57-19	7906-7909	MNI	_
57-20	7910-7916	coords	_
57-21	7917-7918	:	_
57-22	7919-7922	-30	_
57-23	7923-7924	,	_
57-24	7925-7928	-12	_
57-25	7929-7930	,	_
57-26	7931-7934	-22	_
57-27	7935-7936	;	_
57-28	7937-7939	32	_
57-29	7940-7941	,	_
57-30	7942-7945	-14	_
57-31	7946-7947	,	_
57-32	7948-7951	-22	_
57-33	7952-7953	)	_
57-34	7954-7963	resulting	_
57-35	7964-7968	with	_
57-36	7969-7972	245	_
57-37	7973-7978	nodes	_
57-38	7979-7985	across	_
57-39	7986-7989	the	_
57-40	7990-8001	whole-brain	_
57-41	8002-8003	.	_

58-1	8004-8015	Beta-series	_
58-2	8016-8024	pairwise	_
58-3	8025-8037	correlations	_
58-4	8038-8041	for	_
58-5	8042-8045	all	_
58-6	8046-8049	245	_
58-7	8050-8055	nodes	_
58-8	8056-8060	were	_
58-9	8061-8070	extracted	_
58-10	8071-8074	and	_
58-11	8075-8088	z-transformed	_
58-12	8089-8098	resulting	_
58-13	8099-8103	with	_
58-14	8104-8105	a	_
58-15	8106-8109	245	_
58-16	8110-8112	by	_
58-17	8113-8116	245	_
58-18	8117-8129	connectivity	_
58-19	8130-8136	matrix	_
58-20	8137-8138	.	_

59-1	8139-8146	Finally	_
59-2	8147-8148	,	_
59-3	8149-8161	connectivity	_
59-4	8162-8170	matrices	_
59-5	8171-8175	were	_
59-6	8176-8183	reduced	_
59-7	8184-8186	to	_
59-8	8187-8188	a	_
59-9	8189-8195	subset	_
59-10	8196-8198	of	_
59-11	8199-8209	thirty-one	_
59-12	8210-8215	nodes	_
59-13	8216-8220	that	_
59-14	8221-8229	included	_
59-15	8230-8233	the	_
59-16	8234-8237	FPN	_
59-17	8238-8240	as	_
59-18	8241-8245	well	_
59-19	8246-8248	as	_
59-20	8249-8254	nodes	_
59-21	8255-8257	in	_
59-22	8258-8261	the	_
59-23	8262-8272	hippocampi	_
59-24	8273-8276	and	_
59-25	8277-8292	para-hippocampi	_
59-26	8293-8294	(	_
59-27	8295-8298	Fig	_
59-28	8299-8300	.	_

60-1	8301-8302	1	_
60-2	8303-8304	:	_
60-3	8305-8309	Step	_
60-4	8310-8311	4	_
60-5	8312-8313	)	_
60-6	8314-8315	.	_

61-1	8316-8320	This	_
61-2	8321-8327	subset	_
61-3	8328-8330	of	_
61-4	8331-8336	nodes	_
61-5	8337-8340	was	_
61-6	8341-8347	chosen	_
61-7	8348-8351	due	_
61-8	8352-8354	to	_
61-9	8355-8358	the	_
61-10	8359-8364	known	_
61-11	8365-8376	association	_
61-12	8377-8379	of	_
61-13	8380-8383	the	_
61-14	8384-8387	FPN	_
61-15	8388-8392	with	_
61-16	8393-8402	cognitive	_
61-17	8403-8410	control	_
61-18	8411-8414	and	_
61-19	8415-8426	hippocampal	_
61-20	8427-8437	engagement	_
61-21	8438-8444	during	_
61-22	8445-8453	episodic	_
61-23	8454-8460	memory	_
61-24	8461-8466	tasks	_
61-25	8467-8468	.	_

62-1	8469-8470	A	_
62-2	8471-8480	secondary	_
62-3	8481-8487	subset	_
62-4	8488-8490	of	_
62-5	8491-8496	nodes	_
62-6	8497-8507	associated	_
62-7	8508-8512	with	_
62-8	8513-8516	the	_
62-9	8517-8525	auditory	_
62-10	8526-8533	network	_
62-11	8534-8537	was	_
62-12	8538-8547	extracted	_
62-13	8548-8551	for	_
62-14	8552-8557	graph	_
62-15	8558-8566	analysis	_
62-16	8567-8569	to	_
62-17	8570-8575	serve	_
62-18	8576-8578	as	_
62-19	8579-8580	a	_
62-20	8581-8591	comparable	_
62-21	8592-8593	,	_
62-22	8594-8595	“	_
62-23	8596-8603	control	_
62-24	8604-8605	”	_
62-25	8606-8613	network	_
62-26	8614-8616	as	_
62-27	8617-8619	it	_
62-28	8620-8626	should	_
62-29	8627-8630	not	_
62-30	8631-8633	be	_
62-31	8634-8644	influenced	_
62-32	8645-8647	by	_
62-33	8648-8657	cognitive	_
62-34	8658-8665	control	_
62-35	8666-8667	.	_

63-1	8668-8673	Graph	_
63-2	8674-8682	analysis	_
63-3	8683-8686	The	_
63-4	8687-8703	generalizability	_
63-5	8704-8705	,	_
63-6	8706-8709	and	_
63-7	8710-8718	inherent	_
63-8	8719-8730	flexibility	_
63-9	8731-8733	of	_
63-10	8734-8739	graph	_
63-11	8740-8751	theoretical	_
63-12	8752-8760	analysis	_
63-13	8761-8767	allows	_
63-14	8768-8770	us	_
63-15	8771-8773	to	_
63-16	8774-8782	leverage	_
63-17	8783-8786	the	_
63-18	8787-8798	information	_
63-19	8799-8808	contained	_
63-20	8809-8815	within	_
63-21	8816-8819	the	_
63-22	8820-8824	fMRI	_
63-23	8825-8829	BOLD	_
63-24	8830-8836	signal	_
63-25	8837-8839	to	_
63-26	8840-8844	test	_
63-27	8845-8855	hypotheses	_
63-28	8856-8865	regarding	_
63-29	8866-8869	the	_
63-30	8870-8880	functional	_
63-31	8881-8893	organization	_
63-32	8894-8896	of	_
63-33	8897-8900	the	_
63-34	8901-8906	human	_
63-35	8907-8912	brain	_
63-36	8913-8914	.	_

64-1	8915-8920	Given	_
64-2	8921-8924	our	_
64-3	8925-8933	interest	_
64-4	8934-8936	in	_
64-5	8937-8942	local	_
64-6	8943-8946	and	_
64-7	8947-8953	global	_
64-8	8954-8961	network	_
64-9	8962-8969	changes	_
64-10	8970-8971	,	_
64-11	8972-8974	as	_
64-12	8975-8979	well	_
64-13	8980-8982	as	_
64-14	8983-8990	changes	_
64-15	8991-8997	across	_
64-16	8998-9002	task	_
64-17	9003-9013	conditions	_
64-18	9014-9017	and	_
64-19	9018-9029	populations	_
64-20	9030-9031	,	_
64-21	9032-9034	we	_
64-22	9035-9043	employed	_
64-23	9044-9047	two	_
64-24	9048-9061	complimentary	_
64-25	9062-9069	methods	_
64-26	9070-9072	of	_
64-27	9073-9078	graph	_
64-28	9079-9085	theory	_
64-29	9086-9087	:	_
64-30	9088-9091	the	_
64-31	9092-9097	Brain	_
64-32	9098-9110	Connectivity	_
64-33	9111-9118	Toolbox	_
64-34	9119-9120	,	_
64-35	9121-9124	and	_
64-36	9125-9138	Network-based	_
64-37	9139-9148	Statistic	_
64-38	9149-9150	.	_

65-1	9151-9164	Network-based	_
65-2	9165-9174	statistic	_
65-3	9175-9176	(	_
65-4	9177-9180	NBS	_
65-5	9181-9182	)	_
65-6	9183-9186	NBS	_
65-7	9187-9189	is	_
65-8	9190-9191	a	_
65-9	9192-9197	graph	_
65-10	9198-9204	theory	_
65-11	9205-9210	based	_
65-12	9211-9217	method	_
65-13	9218-9222	that	_
65-14	9223-9231	provides	_
65-15	9232-9233	a	_
65-16	9234-9245	statistical	_
65-17	9246-9254	approach	_
65-18	9255-9257	to	_
65-19	9258-9266	identify	_
65-20	9267-9278	connections	_
65-21	9279-9281	in	_
65-22	9282-9283	a	_
65-23	9284-9289	graph	_
65-24	9290-9294	that	_
65-25	9295-9298	may	_
65-26	9299-9301	be	_
65-27	9302-9312	associated	_
65-28	9313-9317	with	_
65-29	9318-9319	a	_
65-30	9320-9330	diagnostic	_
65-31	9331-9337	status	_
65-32	9338-9340	or	_
65-33	9341-9349	changing	_
65-34	9350-9363	psychological	_
65-35	9364-9372	contexts	_
65-36	9373-9375	in	_
65-37	9376-9386	task-based	_
65-38	9387-9394	studies	_
65-39	9395-9396	.	_

66-1	9397-9401	This	_
66-2	9402-9408	method	_
66-3	9409-9414	tests	_
66-4	9415-9418	the	_
66-5	9419-9423	null	_
66-6	9424-9434	hypothesis	_
66-7	9435-9439	with	_
66-8	9440-9447	respect	_
66-9	9448-9450	to	_
66-10	9451-9454	the	_
66-11	9455-9459	size	_
66-12	9460-9462	of	_
66-13	9463-9477	interconnected	_
66-14	9478-9488	components	_
66-15	9489-9491	of	_
66-16	9492-9497	edges	_
66-17	9498-9499	,	_
66-18	9500-9506	rather	_
66-19	9507-9511	than	_
66-20	9512-9524	individually	_
66-21	9525-9527	at	_
66-22	9528-9532	each	_
66-23	9533-9543	connection	_
66-24	9544-9545	.	_

67-1	9546-9548	In	_
67-2	9549-9553	this	_
67-3	9554-9561	context	_
67-4	9562-9563	,	_
67-5	9564-9565	a	_
67-6	9566-9571	graph	_
67-7	9572-9581	component	_
67-8	9582-9588	refers	_
67-9	9589-9591	to	_
67-10	9592-9593	a	_
67-11	9594-9604	collection	_
67-12	9605-9607	of	_
67-13	9608-9613	nodes	_
67-14	9614-9618	that	_
67-15	9619-9622	can	_
67-16	9623-9625	be	_
67-17	9626-9632	linked	_
67-18	9633-9641	together	_
67-19	9642-9645	via	_
67-20	9646-9647	a	_
67-21	9648-9651	set	_
67-22	9652-9654	of	_
67-23	9655-9669	suprathreshold	_
67-24	9670-9675	edges	_
67-25	9676-9677	.	_

68-1	9678-9681	The	_
68-2	9682-9686	size	_
68-3	9687-9689	of	_
68-4	9690-9695	these	_
68-5	9696-9706	components	_
68-6	9707-9709	is	_
68-7	9710-9720	determined	_
68-8	9721-9730	following	_
68-9	9731-9742	application	_
68-10	9743-9745	of	_
68-11	9746-9747	a	_
68-12	9748-9755	primary	_
68-13	9756-9757	,	_
68-14	9758-9775	component-forming	_
68-15	9776-9785	threshold	_
68-16	9786-9788	to	_
68-17	9789-9792	the	_
68-18	9793-9797	data	_
68-19	9798-9799	.	_

69-1	9800-9804	This	_
69-2	9805-9813	approach	_
69-3	9814-9820	offers	_
69-4	9821-9834	substantially	_
69-5	9835-9839	more	_
69-6	9840-9845	power	_
69-7	9846-9850	than	_
69-8	9851-9854	the	_
69-9	9855-9858	FDR	_
69-10	9859-9862	for	_
69-11	9863-9874	identifying	_
69-12	9875-9887	sub-networks	_
69-13	9888-9890	of	_
69-14	9891-9896	edges	_
69-15	9897-9904	showing	_
69-16	9905-9906	a	_
69-17	9907-9913	common	_
69-18	9914-9920	effect	_
69-19	9921-9922	.	_

70-1	9923-9925	We	_
70-2	9926-9934	employed	_
70-3	9935-9938	the	_
70-4	9939-9942	NBS	_
70-5	9943-9945	to	_
70-6	9946-9953	examine	_
70-7	9954-9964	functional	_
70-8	9965-9972	network	_
70-9	9973-9984	differences	_
70-10	9985-9992	between	_
70-11	9993-9998	high-	_
70-12	9999-10002	and	_
70-13	10003-10014	low-control	_
70-14	10015-10025	conditions	_
70-15	10026-10027	(	_
70-16	10028-10031	i.e	_
70-17	10032-10033	.	_

71-1	10034-10038	RiSE	_
71-2	10039-10040	:	_
71-3	10041-10045	item	_
71-4	10046-10049	vs.	_
71-5	10050-10058	relation	_
71-6	10059-10060	,	_
71-7	10061-10064	DPX	_
71-8	10065-10066	:	_
71-9	10067-10068	A	_
71-10	10069-10072	Cue	_
71-11	10073-10076	vs.	_
71-12	10077-10078	B	_
71-13	10079-10082	Cue	_
71-14	10083-10084	)	_
71-15	10085-10086	,	_
71-16	10087-10090	the	_
71-17	10091-10095	main	_
71-18	10096-10102	effect	_
71-19	10103-10105	of	_
71-20	10106-10111	group	_
71-21	10112-10113	(	_
71-22	10114-10116	HC	_
71-23	10117-10120	vs.	_
71-24	10121-10123	SZ	_
71-25	10124-10125	)	_
71-26	10126-10127	,	_
71-27	10128-10131	and	_
71-28	10132-10134	to	_
71-29	10135-10143	identify	_
71-30	10144-10155	interaction	_
71-31	10156-10163	effects	_
71-32	10164-10166	of	_
71-33	10167-10172	group	_
71-34	10173-10176	and	_
71-35	10177-10181	task	_
71-36	10182-10183	.	_

72-1	10184-10194	Functional	_
72-2	10195-10202	network	_
72-3	10203-10214	differences	_
72-4	10215-10219	were	_
72-5	10220-10226	tested	_
72-6	10227-10233	across	_
72-7	10234-10235	a	_
72-8	10236-10241	range	_
72-9	10242-10244	of	_
72-10	10245-10257	t-thresholds	_
72-11	10258-10260	to	_
72-12	10261-10267	ensure	_
72-13	10268-10271	the	_
72-14	10272-10283	reliability	_
72-15	10284-10286	of	_
72-16	10287-10294	results	_
72-17	10295-10296	.	_

73-1	10297-10304	Results	_
73-2	10305-10314	presented	_
73-3	10315-10324	represent	_
73-4	10325-10335	functional	_
73-5	10336-10343	network	_
73-6	10344-10355	differences	_
73-7	10356-10359	for	_
73-8	10360-10361	t	_
73-9	10362-10363	>	_
73-10	10364-10367	2.5	_
73-11	10368-10369	(	_
73-12	10370-10374	5000	_
73-13	10375-10387	permutations	_
73-14	10388-10389	)	_
73-15	10390-10391	,	_
73-16	10392-10394	as	_
73-17	10395-10397	it	_
73-18	10398-10406	provided	_
73-19	10407-10410	the	_
73-20	10411-10415	most	_
73-21	10416-10422	robust	_
73-22	10423-10431	findings	_
73-23	10432-10438	across	_
73-24	10439-10440	a	_
73-25	10441-10448	uniform	_
73-26	10449-10460	t-threshold	_
73-27	10461-10462	.	_

74-1	10463-10468	Brain	_
74-2	10469-10481	Connectivity	_
74-3	10482-10489	Toolbox	_
74-4	10490-10491	(	_
74-5	10492-10495	BCT	_
74-6	10496-10497	)	_
74-7	10498-10501	The	_
74-8	10502-10505	BCT	_
74-9	10506-10508	is	_
74-10	10509-10510	a	_
74-11	10511-10518	network	_
74-12	10519-10527	analysis	_
74-13	10528-10532	tool	_
74-14	10533-10536	for	_
74-15	10537-10546	exploring	_
74-16	10547-10559	connectivity	_
74-17	10560-10573	relationships	_
74-18	10574-10576	in	_
74-19	10577-10581	both	_
74-20	10582-10592	individual	_
74-21	10593-10601	subjects	_
74-22	10602-10605	and	_
74-23	10606-10613	subject	_
74-24	10614-10620	groups	_
74-25	10621-10622	.	_

75-1	10623-10630	Metrics	_
75-2	10631-10640	supported	_
75-3	10641-10643	by	_
75-4	10644-10647	the	_
75-5	10648-10651	BCT	_
75-6	10652-10659	provide	_
75-7	10660-10665	means	_
75-8	10666-10668	to	_
75-9	10669-10676	measure	_
75-10	10677-10687	Functional	_
75-11	10688-10699	Segregation	_
75-12	10700-10701	,	_
75-13	10702-10712	Functional	_
75-14	10713-10724	Integration	_
75-15	10725-10726	,	_
75-16	10727-10730	and	_
75-17	10731-10741	Resilience	_
75-18	10742-10744	of	_
75-19	10745-10746	a	_
75-20	10747-10752	given	_
75-21	10753-10760	network	_
75-22	10761-10762	.	_

76-1	10763-10767	Here	_
76-2	10768-10769	,	_
76-3	10770-10773	the	_
76-4	10774-10777	BCT	_
76-5	10778-10781	was	_
76-6	10782-10786	used	_
76-7	10787-10789	to	_
76-8	10790-10797	measure	_
76-9	10798-10810	quantifiable	_
76-10	10811-10818	changes	_
76-11	10819-10821	of	_
76-12	10822-10832	functional	_
76-13	10833-10840	network	_
76-14	10841-10853	organization	_
76-15	10854-10860	across	_
76-16	10861-10865	each	_
76-17	10866-10875	condition	_
76-18	10876-10885	presented	_
76-19	10886-10892	within	_
76-20	10893-10896	the	_
76-21	10897-10901	RiSE	_
76-22	10902-10905	and	_
76-23	10906-10909	DPX	_
76-24	10910-10915	tasks	_
76-25	10916-10918	in	_
76-26	10919-10923	both	_
76-27	10924-10931	healthy	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
76-28	10932-10938	adults	http://maven.renci.org/NeuroBridge/neurobridge#NoKnownDisorder
76-29	10939-10942	and	_
76-30	10943-10948	those	_
76-31	10949-10953	with	_
76-32	10954-10967	schizophrenia	http://maven.renci.org/NeuroBridge/neurobridge#Schizophrenia
76-33	10968-10969	.	_

77-1	10970-10975	These	_
77-2	10976-10984	analyses	_
77-3	10985-10989	were	_
77-4	10990-10999	performed	_
77-5	11000-11011	independent	_
77-6	11012-11014	of	_
77-7	11015-11018	NBS	_
77-8	11019-11024	tests	_
77-9	11025-11026	.	_

78-1	11027-11034	Changes	_
78-2	11035-11037	in	_
78-3	11038-11045	network	_
78-4	11046-11054	topology	_
78-5	11055-11057	To	_
78-6	11058-11066	identify	_
78-7	11067-11078	topological	_
78-8	11079-11089	properties	_
78-9	11090-11094	that	_
78-10	11095-11101	varied	_
78-11	11102-11106	with	_
78-12	11107-11112	group	_
78-13	11113-11115	or	_
78-14	11116-11125	cognitive	_
78-15	11126-11133	control	_
78-16	11134-11140	demand	_
78-17	11141-11142	,	_
78-18	11143-11146	the	_
78-19	11147-11153	global	_
78-20	11154-11164	efficiency	_
78-21	11165-11166	,	_
78-22	11167-11179	transitivity	_
78-23	11180-11181	,	_
78-24	11182-11185	and	_
78-25	11186-11199	assortativity	_
78-26	11200-11201	(	_
78-27	11202-11215	Supplementary	_
78-28	11216-11221	Table	_
78-29	11222-11223	1	_
78-30	11224-11225	)	_
78-31	11226-11230	were	_
78-32	11231-11241	calculated	_
78-33	11242-11245	for	_
78-34	11246-11249	the	_
78-35	11250-11253	top	_
78-36	11254-11256	10	_
78-37	11257-11258	%	_
78-38	11259-11268	strongest	_
78-39	11269-11279	functional	_
78-40	11280-11291	connections	_
78-41	11292-11293	.	_

79-1	11294-11306	Thresholding	_
79-2	11307-11309	is	_
79-3	11310-11318	standard	_
79-4	11319-11327	practice	_
79-5	11328-11330	in	_
79-6	11331-11336	graph	_
79-7	11337-11343	theory	_
79-8	11344-11354	literature	_
79-9	11355-11357	as	_
79-10	11358-11360	it	_
79-11	11361-11367	serves	_
79-12	11368-11375	several	_
79-13	11376-11390	methodological	_
79-14	11391-11399	purposes	_
79-15	11400-11401	.	_

80-1	11402-11404	We	_
80-2	11405-11413	employed	_
80-3	11414-11415	a	_
80-4	11416-11425	stringent	_
80-5	11426-11435	threshold	_
80-6	11436-11438	to	_
80-7	11439-11447	increase	_
80-8	11448-11459	specificity	_
80-9	11460-11461	(	_
80-10	11462-11465	i.e	_
80-11	11466-11467	.	_

81-1	11468-11473	limit	_
81-2	11474-11477	the	_
81-3	11478-11484	number	_
81-4	11485-11487	of	_
81-5	11488-11493	false	_
81-6	11494-11502	positive	_
81-7	11503-11514	connections	_
81-8	11515-11516	)	_
81-9	11517-11518	.	_

82-1	11519-11523	Most	_
82-2	11524-11535	importantly	_
82-3	11536-11537	,	_
82-4	11538-11550	proportional	_
82-5	11551-11563	thresholding	_
82-6	11564-11570	allows	_
82-7	11571-11574	for	_
82-8	11575-11585	comparison	_
82-9	11586-11588	of	_
82-10	11589-11595	graphs	_
82-11	11596-11602	across	_
82-12	11603-11609	groups	_
82-13	11610-11614	that	_
82-14	11615-11618	may	_
82-15	11619-11623	have	_
82-16	11624-11633	different	_
82-17	11634-11647	distributions	_
82-18	11648-11650	of	_
82-19	11651-11662	correlation	_
82-20	11663-11672	magnitude	_
82-21	11673-11674	,	_
82-22	11675-11676	a	_
82-23	11677-11683	common	_
82-24	11684-11691	finding	_
82-25	11692-11694	in	_
82-26	11695-11698	the	_
82-27	11699-11712	schizophrenia	_
82-28	11713-11723	literature	_
82-29	11724-11725	.	_

83-1	11726-11733	Notably	_
83-2	11734-11735	,	_
83-3	11736-11743	network	_
83-4	11744-11751	metrics	_
83-5	11752-11756	were	_
83-6	11757-11767	calculated	_
83-7	11768-11774	across	_
83-8	11775-11776	a	_
83-9	11777-11782	range	_
83-10	11783-11785	of	_
83-11	11786-11796	thresholds	_
83-12	11797-11799	to	_
83-13	11800-11806	ensure	_
83-14	11807-11810	the	_
83-15	11811-11820	stability	_
83-16	11821-11823	of	_
83-17	11824-11827	our	_
83-18	11828-11836	findings	_
83-19	11837-11838	(	_
83-20	11839-11852	Supplementary	_
83-21	11853-11856	Fig	_
83-22	11857-11858	.	_

84-1	11859-11861	S3	_
84-2	11862-11863	)	_
84-3	11864-11865	.	_

85-1	11866-11867	A	_
85-2	11868-11885	repeated-measures	_
85-3	11886-11891	ANOVA	_
85-4	11892-11895	was	_
85-5	11896-11905	performed	_
85-6	11906-11908	to	_
85-7	11909-11917	identify	_
85-8	11918-11922	main	_
85-9	11923-11930	effects	_
85-10	11931-11933	of	_
85-11	11934-11938	task	_
85-12	11939-11940	,	_
85-13	11941-11944	and	_
85-14	11945-11949	main	_
85-15	11950-11957	effects	_
85-16	11958-11960	of	_
85-17	11961-11966	group	_
85-18	11967-11970	for	_
85-19	11971-11974	the	_
85-20	11975-11980	three	_
85-21	11981-11992	topological	_
85-22	11993-12003	properties	_
85-23	12004-12013	extracted	_
85-24	12014-12017	for	_
85-25	12018-12022	RiSE	_
85-26	12023-12026	and	_
85-27	12027-12030	DPX	_
85-28	12031-12036	tasks	_
85-29	12037-12038	.	_

86-1	12039-12051	Transitivity	_
86-2	12052-12053	,	_
86-3	12054-12056	an	_
86-4	12057-12062	index	_
86-5	12063-12065	of	_
86-6	12066-12076	functional	_
86-7	12077-12088	segregation	_
86-8	12089-12090	,	_
86-9	12091-12099	measures	_
86-10	12100-12103	the	_
86-11	12104-12110	amount	_
86-12	12111-12113	of	_
86-13	12114-12124	clustering	_
86-14	12125-12127	in	_
86-15	12128-12129	a	_
86-16	12130-12137	network	_
86-17	12138-12139	.	_

87-1	12140-12149	Otherwise	_
87-2	12150-12155	known	_
87-3	12156-12158	as	_
87-4	12159-12162	the	_
87-5	12163-12173	clustering	_
87-6	12174-12185	coefficient	_
87-7	12186-12187	,	_
87-8	12188-12190	it	_
87-9	12191-12193	is	_
87-10	12194-12195	a	_
87-11	12196-12201	ratio	_
87-12	12202-12204	of	_
87-13	12205-12214	triangles	_
87-14	12215-12217	to	_
87-15	12218-12226	triplets	_
87-16	12227-12229	in	_
87-17	12230-12231	a	_
87-18	12232-12237	graph	_
87-19	12238-12239	,	_
87-20	12240-12245	which	_
87-21	12246-12254	measures	_
87-22	12255-12258	the	_
87-23	12259-12265	extent	_
87-24	12266-12268	to	_
87-25	12269-12274	which	_
87-26	12275-12284	neighbors	_
87-27	12285-12287	of	_
87-28	12288-12289	a	_
87-29	12290-12294	node	_
87-30	12295-12299	also	_
87-31	12300-12307	connect	_
87-32	12308-12310	to	_
87-33	12311-12315	each	_
87-34	12316-12321	other	_
87-35	12322-12323	.	_

88-1	12324-12333	Increased	_
88-2	12334-12346	transitivity	_
88-3	12347-12348	,	_
88-4	12349-12354	often	_
88-5	12355-12365	associated	_
88-6	12366-12370	with	_
88-7	12371-12378	greater	_
88-8	12379-12389	functional	_
88-9	12390-12404	specialization	_
88-10	12405-12406	,	_
88-11	12407-12410	has	_
88-12	12411-12415	been	_
88-13	12416-12424	observed	_
88-14	12425-12431	during	_
88-15	12432-12441	cognitive	_
88-16	12442-12449	control	_
88-17	12450-12460	assessment	_
88-18	12461-12466	using	_
88-19	12467-12470	the	_
88-20	12471-12481	color-word	http://maven.renci.org/NeuroBridge/neurobridge#ControlledOralWordAssociationTestOfTheMultilingualAphasiaExamination
88-21	12482-12488	Stroop	http://maven.renci.org/NeuroBridge/neurobridge#ControlledOralWordAssociationTestOfTheMultilingualAphasiaExamination
88-22	12489-12493	task	http://maven.renci.org/NeuroBridge/neurobridge#ControlledOralWordAssociationTestOfTheMultilingualAphasiaExamination
88-23	12494-12495	.	_

89-1	12496-12500	Thus	_
89-2	12501-12503	we	_
89-3	12504-12511	predict	_
89-4	12512-12521	increased	_
89-5	12522-12534	transitivity	_
89-6	12535-12540	would	_
89-7	12541-12543	be	_
89-8	12544-12554	associated	_
89-9	12555-12559	with	_
89-10	12560-12561	a	_
89-11	12562-12569	greater	_
89-12	12570-12576	demand	_
89-13	12577-12580	for	_
89-14	12581-12590	cognitive	_
89-15	12591-12598	control	_
89-16	12599-12600	.	_

90-1	12601-12607	Global	_
90-2	12608-12618	efficiency	_
90-3	12619-12620	,	_
90-4	12621-12622	a	_
90-5	12623-12630	measure	_
90-6	12631-12633	of	_
90-7	12634-12644	functional	_
90-8	12645-12656	integration	_
90-9	12657-12658	,	_
90-10	12659-12668	describes	_
90-11	12669-12672	how	_
90-12	12673-12677	well	_
90-13	12678-12679	a	_
90-14	12680-12687	network	_
90-15	12688-12691	can	_
90-16	12692-12699	combine	_
90-17	12700-12711	specialized	_
90-18	12712-12723	information	_
90-19	12724-12730	across	_
90-20	12731-12742	distributed	_
90-21	12743-12750	regions	_
90-22	12751-12752	.	_

91-1	12753-12759	Global	_
91-2	12760-12770	efficiency	_
91-3	12771-12773	is	_
91-4	12774-12777	the	_
91-5	12778-12785	inverse	_
91-6	12786-12793	average	_
91-7	12794-12802	shortest	_
91-8	12803-12807	path	_
91-9	12808-12814	length	_
91-10	12815-12817	of	_
91-11	12818-12819	a	_
91-12	12820-12825	graph	_
91-13	12826-12829	and	_
91-14	12830-12832	is	_
91-15	12833-12834	a	_
91-16	12835-12842	measure	_
91-17	12843-12845	of	_
91-18	12846-12854	parallel	_
91-19	12855-12866	information	_
91-20	12867-12875	transfer	_
91-21	12876-12877	.	_

92-1	12878-12886	Previous	_
92-2	12887-12909	magnetoencephalography	_
92-3	12910-12913	and	_
92-4	12914-12918	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
92-5	12919-12926	studies	_
92-6	12927-12931	have	_
92-7	12932-12940	observed	_
92-8	12941-12950	increased	_
92-9	12951-12957	global	_
92-10	12958-12968	efficiency	_
92-11	12969-12979	associated	_
92-12	12980-12984	with	_
92-13	12985-12989	task	_
92-14	12990-12996	demand	_
92-15	12997-12999	in	_
92-16	13000-13007	working	_
92-17	13008-13014	memory	_
92-18	13015-13016	.	_

93-1	13017-13026	Similarly	_
93-2	13027-13028	,	_
93-3	13029-13031	we	_
93-4	13032-13039	predict	_
93-5	13040-13049	increased	_
93-6	13050-13056	global	_
93-7	13057-13067	efficiency	_
93-8	13068-13073	would	_
93-9	13074-13076	be	_
93-10	13077-13087	associated	_
93-11	13088-13092	with	_
93-12	13093-13094	a	_
93-13	13095-13102	greater	_
93-14	13103-13109	demand	_
93-15	13110-13113	for	_
93-16	13114-13123	cognitive	_
93-17	13124-13131	control	_
93-18	13132-13133	.	_

94-1	13134-13147	Assortativity	_
94-2	13148-13149	,	_
94-3	13150-13152	an	_
94-4	13153-13158	index	_
94-5	13159-13161	of	_
94-6	13162-13172	resilience	_
94-7	13173-13174	,	_
94-8	13175-13185	quantifies	_
94-9	13186-13189	the	_
94-10	13190-13201	correlation	_
94-11	13202-13209	between	_
94-12	13210-13213	the	_
94-13	13214-13220	degree	_
94-14	13221-13223	of	_
94-15	13224-13225	a	_
94-16	13226-13230	node	_
94-17	13231-13234	and	_
94-18	13235-13238	the	_
94-19	13239-13243	mean	_
94-20	13244-13250	degree	_
94-21	13251-13253	of	_
94-22	13254-13257	its	_
94-23	13258-13265	nearest	_
94-24	13266-13275	neighbors	_
94-25	13276-13277	,	_
94-26	13278-13283	which	_
94-27	13284-13294	identifies	_
94-28	13295-13298	the	_
94-29	13299-13305	extent	_
94-30	13306-13308	to	_
94-31	13309-13314	which	_
94-32	13315-13321	highly	_
94-33	13322-13331	connected	_
94-34	13332-13337	nodes	_
94-35	13338-13341	are	_
94-36	13342-13351	connected	_
94-37	13352-13354	to	_
94-38	13355-13360	other	_
94-39	13361-13367	highly	_
94-40	13368-13377	connected	_
94-41	13378-13383	nodes	_
94-42	13384-13385	.	_

95-1	13386-13388	In	_
95-2	13389-13395	highly	_
95-3	13396-13407	assortative	_
95-4	13408-13416	networks	_
95-5	13417-13418	,	_
95-6	13419-13423	high	_
95-7	13424-13430	degree	_
95-8	13431-13436	nodes	_
95-9	13437-13438	(	_
95-10	13439-13441	or	_
95-11	13442-13446	hubs	_
95-12	13447-13448	)	_
95-13	13449-13452	are	_
95-14	13453-13459	likely	_
95-15	13460-13462	to	_
95-16	13463-13465	be	_
95-17	13466-13475	connected	_
95-18	13476-13478	to	_
95-19	13479-13483	each	_
95-20	13484-13489	other	_
95-21	13490-13491	,	_
95-22	13492-13495	and	_
95-23	13496-13500	thus	_
95-24	13501-13504	are	_
95-25	13505-13509	more	_
95-26	13510-13519	resilient	_
95-27	13520-13522	to	_
95-28	13523-13533	disruption	_
95-29	13534-13535	(	_
95-30	13536-13540	e.g.	_
95-31	13541-13542	,	_
95-32	13543-13550	removal	_
95-33	13551-13553	of	_
95-34	13554-13559	nodes	_
95-35	13560-13561	)	_
95-36	13562-13569	because	_
95-37	13570-13573	the	_
95-38	13574-13578	core	_
95-39	13579-13581	of	_
95-40	13582-13588	highly	_
95-41	13589-13598	connected	_
95-42	13599-13604	nodes	_
95-43	13605-13613	provides	_
95-44	13614-13623	redundant	_
95-45	13624-13635	connections	_
95-46	13636-13642	within	_
95-47	13643-13646	the	_
95-48	13647-13652	graph	_
95-49	13653-13654	.	_

96-1	13655-13657	We	_
96-2	13658-13665	predict	_
96-3	13666-13670	that	_
96-4	13671-13680	increased	_
96-5	13681-13694	assortativity	_
96-6	13695-13699	will	_
96-7	13700-13702	be	_
96-8	13703-13713	associated	_
96-9	13714-13718	with	_
96-10	13719-13721	an	_
96-11	13722-13731	increased	_
96-12	13732-13738	demand	_
96-13	13739-13742	for	_
96-14	13743-13752	cognitive	_
96-15	13753-13760	control	_
96-16	13761-13762	.	_

97-1	13763-13775	Collectively	_
97-2	13776-13777	,	_
97-3	13778-13783	these	_
97-4	13784-13791	network	_
97-5	13792-13802	properties	_
97-6	13803-13807	were	_
97-7	13808-13812	used	_
97-8	13813-13815	to	_
97-9	13816-13830	quantitatively	_
97-10	13831-13837	assess	_
97-11	13838-13841	the	_
97-12	13842-13848	manner	_
97-13	13849-13851	in	_
97-14	13852-13857	which	_
97-15	13858-13863	brain	_
97-16	13864-13872	networks	_
97-17	13873-13883	reorganize	_
97-18	13884-13886	to	_
97-19	13887-13894	support	_
97-20	13895-13904	cognitive	_
97-21	13905-13912	control	_
97-22	13913-13919	during	_
97-23	13920-13923	the	_
97-24	13924-13928	RiSE	_
97-25	13929-13932	and	_
97-26	13933-13936	DPX	_
97-27	13937-13942	tasks	_
97-28	13943-13944	.	_

98-1	13945-13948	The	_
98-2	13949-13961	overwhelming	_
98-3	13962-13970	majority	_
98-4	13971-13973	of	_
98-5	13974-13978	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
98-6	13979-13986	studies	_
98-7	13987-13989	in	_
98-8	13990-13992	SZ	http://maven.renci.org/NeuroBridge/neurobridge#Thing
98-9	13993-13997	have	_
98-10	13998-14008	identified	_
98-11	14009-14021	connectivity	_
98-12	14022-14032	reductions	_
98-13	14033-14035	in	_
98-14	14036-14044	patients	_
98-15	14045-14046	;	_
98-16	14047-14052	these	_
98-17	14053-14061	findings	_
98-18	14062-14069	include	_
98-19	14070-14079	decreased	_
98-20	14080-14090	clustering	_
98-21	14091-14092	,	_
98-22	14093-14099	degree	_
98-23	14100-14101	,	_
98-24	14102-14105	and	_
98-25	14106-14113	hubness	_
98-26	14114-14115	.	_

99-1	14116-14120	Thus	_
99-2	14121-14123	we	_
99-3	14124-14131	predict	_
99-4	14132-14136	that	_
99-5	14137-14149	transitivity	_
99-6	14150-14151	,	_
99-7	14152-14153	a	_
99-8	14154-14161	measure	_
99-9	14162-14164	of	_
99-10	14165-14175	clustering	_
99-11	14176-14177	,	_
99-12	14178-14182	will	_
99-13	14183-14185	be	_
99-14	14186-14195	decreased	_
99-15	14196-14198	in	_
99-16	14199-14207	patients	_
99-17	14208-14209	.	_

100-1	14210-14223	Assortativity	_
100-2	14224-14226	is	_
100-3	14227-14230	the	_
100-4	14231-14242	correlation	_
100-5	14243-14250	between	_
100-6	14251-14254	the	_
100-7	14255-14262	degrees	_
100-8	14263-14265	of	_
100-9	14266-14275	connected	_
100-10	14276-14281	nodes	_
100-11	14282-14283	.	_

101-1	14284-14295	Considering	_
101-2	14296-14300	that	_
101-3	14301-14310	decreased	_
101-4	14311-14315	node	_
101-5	14316-14322	degree	_
101-6	14323-14326	has	_
101-7	14327-14331	been	_
101-8	14332-14340	observed	_
101-9	14341-14343	in	_
101-10	14344-14352	patients	_
101-11	14353-14354	,	_
101-12	14355-14357	we	_
101-13	14358-14365	predict	_
101-14	14366-14370	that	_
101-15	14371-14384	assortativity	_
101-16	14385-14389	will	_
101-17	14390-14394	also	_
101-18	14395-14397	be	_
101-19	14398-14407	decreased	_
101-20	14408-14410	in	_
101-21	14411-14419	patients	_
101-22	14420-14421	.	_

102-1	14422-14429	Despite	_
102-2	14430-14442	inconsistent	_
102-3	14443-14449	global	_
102-4	14450-14460	efficiency	_
102-5	14461-14469	findings	_
102-6	14470-14472	in	_
102-7	14473-14481	patients	_
102-8	14482-14484	at	_
102-9	14485-14489	rest	_
102-10	14490-14491	,	_
102-11	14492-14500	previous	_
102-12	14501-14510	decreased	_
102-13	14511-14521	activation	_
102-14	14522-14530	observed	_
102-15	14531-14537	during	_
102-16	14538-14541	the	_
102-17	14542-14546	RiSE	_
102-18	14547-14550	and	_
102-19	14551-14554	DPX	_
102-20	14555-14564	paradigms	_
102-21	14565-14570	leads	_
102-22	14571-14573	us	_
102-23	14574-14576	to	_
102-24	14577-14584	predict	_
102-25	14585-14589	that	_
102-26	14590-14598	patients	_
102-27	14599-14603	will	_
102-28	14604-14611	exhibit	_
102-29	14612-14621	decreased	_
102-30	14622-14628	global	_
102-31	14629-14639	efficiency	_
102-32	14640-14642	in	_
102-33	14643-14646	the	_
102-34	14647-14650	FPN	_
102-35	14651-14652	.	_

